Novel framework for response evaluation criteria in grade 1/2 neuroendocrine tumors (RECIN) following [177Lu]Lu-DOTATATE therapy: post-hoc analysis of the phase 2 LuCAP trial.
Saved in:
| Title: | Novel framework for response evaluation criteria in grade 1/2 neuroendocrine tumors (RECIN) following [177Lu]Lu-DOTATATE therapy: post-hoc analysis of the phase 2 LuCAP trial. |
|---|---|
| Authors: | Satapathy, Swayamjeet1 (AUTHOR) swayamjeet.satapathy@gmail.com, Aggarwal, Piyush1 (AUTHOR), Sood, Ashwani1 (AUTHOR), Chandekar, Kunal R1,2 (AUTHOR), Das, Chandan K3,4 (AUTHOR), Gupta, Rajesh5 (AUTHOR), Khosla, Divya6 (AUTHOR), Das, Namrata6,7 (AUTHOR), Kapoor, Rakesh6 (AUTHOR), Kumar, Rajender1 (AUTHOR), Singh, Harmandeep1 (AUTHOR), Mittal, Bhagwant R1 (AUTHOR) |
| Source: | European Journal of Nuclear Medicine & Molecular Imaging. Nov2025, Vol. 52 Issue 13, p4902-4912. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 16197070 |
|---|---|
| DOI: | 10.1007/s00259-025-07351-7 |
